» Articles » PMID: 39519313

Unveiling the Predictive Model for Macrovascular Complications in Type 2 Diabetes Mellitus: MicroRNAs Expression, Lipid Profile, and Oxidative Stress Markers

Abstract

To assay new circulating markers related to macrovascular complications (MVC) in type 2 diabetes mellitus (T2DM), we carried out a descriptive cross-sectional study. We recruited 30 controls (CG), 34 patients with T2DM (DG), and 28 patients with T2DM and vascular complications (DG+C); among them, 22 presented MVC. Peripheral blood was used to determine redox status (superoxide dismutase, SOD; catalase, CAT; glutathione reductase, GRd; glutathione peroxidase, GPx; glucose-6-phosphate dehydrogenase, G6PD) and markers of oxidative damage (advanced oxidation protein products, AOPP; lipid peroxidation, LPO), nitrite levels in plasma (NOx). Inflammatory markers (IL-1β, IL-6, IL-10, IL-18, MCP-1, TNF-α) and the relative expression of c-miRNAs were analyzed. The real-time PCR results showed that the expressions of miR-155-5p, miR-21-5p, miR-146a-3p, and miR-210-3p were significantly higher in the DG group compared to the CG. The DG+C group presented statistically relevant differences with CG for four miRs: the increased expression of miR-484-5p, miR-21-5p, and miR-210-3p, and decreased expression of miR-126a-3p. Moreover, miR-126a-3p was significantly less expressed in DG+C compared to DG. The application of binary logistic regression analysis and construction of receiving operator characteristic curves (ROC) revealed two models with high predictive values for vascular complications presence: (1) HbAc1, creatinine, total cholesterol (TC), LPO, GPx, SOD, miR-126, miR-484 (Exp(B) = 0.926, chi = 34.093, < 0.001; AUC = 0.913). (2) HbAc1, creatinine, TC, IL-6, LPO, miR-126, miR-484 (Exp(B) = 0.958, Chi = 33.863, < 0.001; AUC = 0.938). Moreover, our data demonstrated that gender, TC, GPx, CAT, and miR-484 were associated with MVC and exhibited higher predictive values (Exp(B) = 0.528, = 0.024, Chi = 28.214, AUC = 0.904) than classical variables (Exp(B) 0.462, = 0.007, Chi = 18.814, AUC = 0.850). miR-126, miR-484, IL-6, SOD, CAT, and GPx participate in vascular damage development in the studied diabetic population and should be considered for future studies.

Citing Articles

Preeclampsia as a Study Model for Aging: The Klotho Gene Paradigm.

Cecati M, Fumarola S, Vaiasicca S, Cianfruglia L, Vignini A, Giannubilo S Int J Mol Sci. 2025; 26(3).

PMID: 39940672 PMC: 11817256. DOI: 10.3390/ijms26030902.


A Narrative Review of the Interplay Between Carbohydrate Intake and Diabetes Medications: Unexplored Connections and Clinical Implications.

Mphasha M, Vagiri R Int J Mol Sci. 2025; 26(2).

PMID: 39859337 PMC: 11765648. DOI: 10.3390/ijms26020624.

References
1.
Seo J, Jung S, Jeon H, Lee Y, Lee J, Han E . Activity-expression profiling of glucose-6-phosphate dehydrogenase in tissues of normal and diabetic mice. Biochem Biophys Res Commun. 2020; 524(3):750-755. DOI: 10.1016/j.bbrc.2020.01.165. View

2.
Sun H, Chen T, Li X, Zhu Y, Zhang S, He P . The relevance of the non-invasive biomarkers lncRNA GAS5/miR-21 ceRNA regulatory network in the early identification of diabetes and diabetic nephropathy. Diabetol Metab Syndr. 2023; 15(1):197. PMC: 10566063. DOI: 10.1186/s13098-023-01179-7. View

3.
Andrade-Sierra J, Pazarin-Villasenor L, Yanowsky-Escatell F, Diaz-de la Cruz E, Garcia-Sanchez A, Cardona-Munoz E . The Influence of the Severity of Early Chronic Kidney Disease on Oxidative Stress in Patients with and without Type 2 Diabetes Mellitus. Int J Mol Sci. 2022; 23(19). PMC: 9569590. DOI: 10.3390/ijms231911196. View

4.
La Sala L, Mrakic-Sposta S, Tagliabue E, Prattichizzo F, Micheloni S, Sangalli E . Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2D. Cardiovasc Diabetol. 2019; 18(1):18. PMC: 6388471. DOI: 10.1186/s12933-019-0824-2. View

5.
Phu T, Ng M, Vu N, Bouchareychas L, Raffai R . IL-4 polarized human macrophage exosomes control cardiometabolic inflammation and diabetes in obesity. Mol Ther. 2022; 30(6):2274-2297. PMC: 9171286. DOI: 10.1016/j.ymthe.2022.03.008. View